In patients with COVID-19 at risk for severe disease, nirmatrelvir + ritonavir reduced hospitalization or death

Athanasios Vassilopoulos, Eleftherios Mylonakis

Research output: Contribution to journalComment/debatepeer-review

9 Scopus citations
Original languageEnglish (US)
Pages (from-to)JC63
JournalAnnals of Internal Medicine
Issue number6
StatePublished - Jun 1 2022

ASJC Scopus subject areas

  • Internal Medicine

Cite this